Antianginal Agents Practice Test

Ranolazine is an antianginal medication specifically approved for the treatment of chronic stable angina. It works by decreasing myocardial oxygen demand and improving blood flow to the heart muscle. This action helps relieve the pain and discomfort associated with angina episodes. Ranolazine is often used in conjunction with other antianginal therapies to enhance efficacy and improve overall patient outcomes.

In contrast, atorvastatin and simvastatin are lipid-lowering agents (statins) that primarily aim to manage cholesterol levels. While lowering cholesterol can reduce the risk of cardiovascular events, these drugs are not indicated for the treatment of angina itself.

Aspirin is an antiplatelet agent used to reduce the risk of thrombus formation, particularly in individuals with cardiovascular disease, but it does not have a direct effect on alleviating angina symptoms. Therefore, it is not classified as an antianginal agent.

Ranolazine stands out as the correct choice because it directly addresses the symptoms of chronic stable angina, making it a valuable option in the management of this condition.